EDWARD MESSINA: Open Payments
NPI 1558706713 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 7 payments from 6 companies in 2025. Trend: 2023 $525 · 2024 $453 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $117 |
| Laborie Medical Technologies Corp. | 2 | $93 |
| COLOPLAST CORP | 1 | $55 |
| W. L. Gore & Associates, Inc. | 1 | $38 |
Products named: AIRSUPRA, Descovy, Optilume BPH Drug Coated Balloon Catheter, Titan, GORE VIABAHN VBX Balloon Expandable Endo.
Industry payments across PA — which companies pay providers there.
